20-year research breakthrough offers new hope for breast cancer patients

(The Royal Marsden NHS Foundation Trust) A new treatment for breast cancer patients with hormone receptor (HR+) early stage disease who are at a high risk of recurrence has been shown to reduce the risk by 25%, according to a study led by The Royal Marsden NHS Foundation Trust.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news